- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 249/08 - 1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Patent holdings for IPC class C07D 249/08
Total number of patents in this class: 1207
10-year publication summary
102
|
120
|
97
|
74
|
67
|
81
|
70
|
52
|
69
|
22
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
BASF SE | 19740 |
66 |
Corteva Agriscience LLC | 2494 |
37 |
Kureha Corporation | 1026 |
30 |
Karyopharm Therapeutics Inc. | 121 |
27 |
Bristol-myers Squibb Company | 5080 |
20 |
Bayer Cropscience AG | 2241 |
19 |
BASF Agro B.V. | 211 |
19 |
Ardea Biosciences, Inc. | 79 |
17 |
Dow AgroSciences LLC | 1267 |
14 |
Merck Sharp & Dohme LLC | 3689 |
14 |
Boehringer Ingelheim International GmbH | 4629 |
13 |
Janssen Pharmaceutica N.V. | 3839 |
13 |
Amgen Inc. | 3779 |
12 |
Biogen MA Inc. | 926 |
11 |
Nippon Soda Co., Ltd. | 890 |
11 |
Synta Pharmaceuticals Corp. | 204 |
11 |
Novartis AG | 11238 |
9 |
Syngenta Participations AG | 4970 |
9 |
Astellas Pharma Inc. | 1145 |
9 |
Theravance Biopharma R&D IP, LLC | 550 |
9 |
Other owners | 837 |